Last 7 days
-1.5%
Last 30 days
-9.0%
Last 90 days
-5.8%
Trailing 12 Months
-18.2%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 176.3B | 31.5B | -6.84% | -10.46% | 24.46 | 5.6 | 6.85% | 12.06% |
MDT | 104.3B | 30.8B | -7.09% | -24.59% | 25.66 | 3.39 | -3.19% | -17.38% |
SYK | 103.3B | 18.4B | 2.26% | 8.00% | 43.81 | 5.6 | 7.84% | 18.25% |
ISRG | 82.0B | 6.2B | -4.47% | -13.27% | 61.99 | 13.17 | 8.97% | -22.43% |
EW | 48.3B | 5.4B | 2.41% | -25.12% | 31.77 | 8.98 | 2.86% | 1.25% |
MID-CAP | ||||||||
PEN | 9.8B | 847.1M | -3.64% | 34.52% | -4.9K | 11.56 | 13.32% | -137.89% |
GMED | 5.2B | 1.0B | -11.64% | -20.31% | 30.37 | 5.12 | 6.76% | 24.45% |
IART | 4.4B | 1.6B | -8.98% | -18.20% | 24.42 | 2.83 | 0.99% | 6.79% |
IRTC | 3.3B | 410.9M | 4.51% | -3.13% | -28.67 | 8.11 | 27.29% | -14.60% |
STAA | 3.0B | 284.4M | -11.77% | 2.91% | 76.18 | 10.38 | 23.40% | 58.18% |
SMALL-CAP | ||||||||
BLFS | 917.3M | 154.8M | -6.04% | 0.61% | -8.82 | 5.93 | 60.29% | -2309.58% |
MLAB | 896.3M | 222.4M | -8.27% | -33.23% | -611.78 | 4.03 | 36.07% | -119.34% |
AXDX | 52.5M | 13.1M | -11.48% | -68.24% | -0.74 | 4 | 13.64% | 4.49% |
AEMD | 8.9M | 3.5M | -28.10% | -68.62% | -0.66 | 2.5 | 44.21% | -50.10% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | -0.5% | 1,558 | 1,565 | 1,567 | 1,559 | 1,542 |
S&GA Expenses | -1.6% | 616 | 627 | 639 | 641 | 637 |
Costs and Expenses | -1.3% | 1,319 | 1,336 | 1,346 | 1,346 | 1,345 |
EBITDA | 5.3% | 263 | 250 | 242 | 236 | - |
EBITDA Margin | 5.8% | 0.17* | 0.16* | 0.15* | 0.15* | - |
Earnings Before Taxes | 6.2% | 214 | 201 | 193 | 187 | 215 |
EBT Margin | 6.7% | 0.14* | 0.13* | 0.12* | 0.12* | - |
Interest Expenses | 1.6% | 50.00 | 49.00 | 48.00 | 49.00 | 50.00 |
Net Income | 4.4% | 181 | 173 | 166 | 157 | 169 |
Net Income Margin | 4.9% | 0.12* | 0.11* | 0.11* | 0.10* | - |
Free Cahsflow | 15.0% | 222 | 193 | 209 | 237 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | 2.2% | 3,890 | 3,807 | 3,753 | 3,672 | 3,782 |
Current Assets | -2.9% | 1,161 | 1,196 | 1,137 | 1,066 | 1,154 |
Cash Equivalents | -10.8% | 457 | 512 | 447 | 407 | 513 |
Inventory | 4.3% | 325 | 311 | 320 | 328 | 317 |
Net PPE | 3.5% | 311 | 301 | 302 | 309 | 312 |
Goodwill | 6.2% | 1,039 | 978 | 990 | 1,009 | 1,013 |
Liabilities | 0.1% | 2,085 | 2,083 | 2,092 | 2,057 | 2,098 |
Current Liabilities | 5.4% | 321 | 304 | 296 | 316 | 340 |
Long Term Debt | -1.4% | 810 | 821 | 833 | - | - |
Shareholder's Equity | 4.6% | 1,804 | 1,724 | 1,661 | 1,615 | 1,685 |
Retained Earnings | 6.4% | 879 | 826 | 776 | 731 | 699 |
Additional Paid-In Capital | 0.7% | 1,277 | 1,268 | 1,260 | 1,267 | 1,265 |
Shares Outstanding | -0.2% | 83.00 | 83.00 | 84.00 | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 6.5% | 264 | 248 | 263 | 288 | 312 |
Share Based Compensation | -2.5% | 28.00 | 28.00 | 27.00 | 36.00 | 36.00 |
Cashflow From Investing | -87.5% | -58.58 | -31.24 | -54.52 | -57.94 | -161 |
Cashflow From Financing | -63.9% | -251 | -153 | -144 | -228 | -98.23 |
Buy Backs | 0% | 125 | 125 | 125 | 125 | 0.00 |
63.1%
48.1%
8.5%
Y-axis is the maximum loss one would have experienced if Integra LifeSciences Holdings was unfortunately bought at previous high price.
10.9%
7.2%
-1.5%
7.0%
FIve years rolling returns for Integra LifeSciences Holdings.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -36.39 | -155,884 | 830,116 | -% |
2023-03-06 | Rockefeller Capital Management L.P. | added | 4.09 | 6,000 | 21,000 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -0.39 | 1,096,780 | 4,541,780 | 0.01% |
2023-02-24 | SRS Capital Advisors, Inc. | unchanged | - | 9.00 | 1,009 | -% |
2023-02-22 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 9.25 | 1,905,000 | 6,173,000 | 0.06% |
2023-02-21 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | added | 25.00 | 4,543 | 14,543 | -% |
2023-02-21 | KB FINANCIAL PARTNERS, LLC | reduced | -2.65 | 1,000 | 6,000 | -% |
2023-02-21 | MACQUARIE GROUP LTD | reduced | -3.01 | 21,125,000 | 95,709,000 | 0.11% |
2023-02-21 | MACQUARIE GROUP LTD | added | 11.81 | 1,250,000 | 6,412,000 | 0.01% |
2023-02-21 | NORTHWESTERN MUTUAL INVESTMENT MANAGEMENT COMPANY, LLC | reduced | -35.92 | -66,985 | 377,015 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | tru st partnership, l.p. | 10.20% | 8,515,930 | SC 13G/A | |
Feb 13, 2023 | champlain investment partners, llc | 6.30% | 5,259,524 | SC 13G/A | |
Feb 09, 2023 | morgan stanley | 6.8% | 5,681,483 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.56% | 7,147,759 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 6.84% | 5,709,663 | SC 13G/A | |
Feb 03, 2023 | blackrock inc. | 8.6% | 7,143,236 | SC 13G/A | |
Jul 08, 2022 | capital research global investors | 4.7% | 3,869,770 | SC 13G/A | |
Feb 14, 2022 | tru st partnership, l.p. | 10.32% | 8,740,930 | SC 13G/A | |
Feb 11, 2022 | champlain investment partners, llc | 6.72% | 5,694,837 | SC 13G/A | |
Feb 11, 2022 | capital research global investors | 9.7% | 8,219,133 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 17.17 -67.66% | 20.06 -62.22% | 32.24 -39.27% | 47.72 -10.11% | 59.83 12.70% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 14, 2023 | 4 | Insider Trading | |
Mar 08, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 03, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-13 | Schwartz Eric | sold (taxes) | -74,183 | 55.7355 | -1,331 | evp, chief legal officer & sec |
2023-03-13 | DAVIS ROBERT T. JR. | sold (taxes) | -77,284 | 52.61 | -1,469 | evp & president, tt |
2023-03-13 | Evoli Lisa | sold (taxes) | -50,453 | 52.61 | -959 | evp & chro |
2023-03-13 | Mosebrook Jeffrey | sold (taxes) | -10,732 | 52.61 | -204 | svp, fin, pfo & pao |
2023-03-13 | McBreen Michael J. | sold (taxes) | -50,137 | 52.61 | -953 | evp & president, css |
2023-03-12 | Evoli Lisa | sold (taxes) | -51,389 | 52.87 | -972 | evp & chro |
2023-03-12 | Schwartz Eric | sold (taxes) | -61,857 | 52.87 | -1,170 | evp, chief legal officer & sec |
2023-03-12 | Mosebrook Jeffrey | sold (taxes) | -15,385 | 52.87 | -291 | svp, fin, pfo & pao |
2023-03-12 | DAVIS ROBERT T. JR. | sold (taxes) | -86,548 | 52.87 | -1,637 | evp & president, tt |
2023-03-12 | McBreen Michael J. | sold (taxes) | -86,125 | 52.87 | -1,629 | evp & president, css |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Income Statement [Abstract] | |||
Total revenue, net | $ 1,557,666 | $ 1,542,448 | $ 1,371,868 |
Costs and expenses: | |||
Cost of goods sold | 587,355 | 597,808 | 520,834 |
Research and development | 101,193 | 93,051 | 77,381 |
Selling, general and administrative | 616,316 | 637,445 | 594,526 |
Intangible asset amortization | 13,882 | 16,914 | 27,757 |
Total costs and expenses | 1,318,746 | 1,345,218 | 1,220,498 |
Operating income | 238,920 | 197,230 | 151,370 |
Interest income | 11,917 | 6,737 | 9,297 |
Interest expense | (49,594) | (50,395) | (71,581) |
Gain from sale of businesses | 644 | 41,798 | 0 |
Other income, net | 12,007 | 19,307 | 4,434 |
Income before income taxes | 213,894 | 214,677 | 93,520 |
Provision (benefit) for income taxes | 33,344 | 45,602 | (40,372) |
Net income | $ 180,550 | $ 169,075 | $ 133,892 |
Net income per share | |||
Basic (in dollars per share) | $ 2.18 | $ 2.00 | $ 1.58 |
Diluted (in dollars per share) | $ 2.16 | $ 1.98 | $ 1.57 |
Weighted average common shares outstanding (See Note 13): | |||
Basic (in shares) | 82,997 | 84,698 | 84,650 |
Diluted (in shares) | 83,516 | 85,485 | 85,228 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current Assets: | ||
Cash and cash equivalents | $ 456,661 | $ 513,448 |
Trade accounts receivable, net of allowances of $4,304 and $4,735 | 263,465 | 231,831 |
Inventories, net | 324,583 | 317,386 |
Prepaid expenses and other current assets | 116,789 | 91,051 |
Total current assets | 1,161,498 | 1,153,716 |
Property, plant and equipment, net | 311,302 | 311,703 |
Right of use asset - operating leases | 148,284 | 84,543 |
Intangible assets, net | 1,126,609 | 1,145,573 |
Goodwill | 1,038,881 | 1,013,458 |
Deferred tax assets, net | 45,994 | 56,950 |
Other assets | 57,190 | 16,440 |
Total assets | 3,889,758 | 3,782,383 |
Current Liabilities: | ||
Current portion of borrowings under senior credit facility | 38,125 | 45,000 |
Current portion of lease liability - operating leases | 14,624 | 14,775 |
Accounts payable, trade | 102,100 | 61,837 |
Contract liabilities | 7,253 | 5,295 |
Accrued compensation | 78,771 | 92,656 |
Accrued expenses and other current liabilities | 80,033 | 120,458 |
Total current liabilities | 320,906 | 340,021 |
Long-term borrowings under senior credit facility | 733,149 | 824,257 |
Long-term borrowings under securitization facility | 104,700 | 112,500 |
Long-term convertible securities | 567,341 | 564,426 |
Lease liability - operating leases | 157,420 | 90,329 |
Deferred tax liabilities | 63,338 | 45,788 |
Other liabilities | 138,501 | 120,258 |
Total liabilities | 2,085,355 | 2,097,579 |
Stockholders’ Equity: | ||
Preferred Stock; no par value; 15,000 authorized shares; none outstanding | 0 | 0 |
Common stock; $0.01 par value; 240,000 authorized shares; 90,477 and 89,600 issued at December 31, 2022 and 2021, respectively | 905 | 896 |
Additional paid-in capital | 1,276,977 | 1,264,943 |
Treasury stock, at cost; 6,823 and 4,899 shares at December 31, 2022 and 2021, respectively | (362,862) | (234,448) |
Accumulated other comprehensive income (loss) | 10,265 | (45,155) |
Retained earnings | 879,118 | 698,568 |
Total stockholders’ equity | 1,804,403 | 1,684,804 |
Total liabilities and stockholders’ equity | $ 3,889,758 | $ 3,782,383 |